BridgeBio 製藥公司
US ˙ NasdaqGS ˙ US10806X1028

SecurityBBIO / BridgeBio Pharma, Inc.
InstitutionONEQ - Fidelity Nasdaq Composite Index Tracking Stock
Latest Disclosed Ownership44,911 shares
Latest Disclosed Value $ 1,538,201
ONEQ - Fidelity Nasdaq Composite Index Tracking Stock reports 10.48% decrease in ownership of BBIO / BridgeBio Pharma, Inc.

On July 24, 2025 - ONEQ - Fidelity Nasdaq Composite Index Tracking Stock filed a NPORT-P form disclosing ownership of 44,911 shares of BridgeBio Pharma, Inc. (US:BBIO) valued at $1,538,202 USD as of May 31, 2025. The entity filed a previous NPORT-P on April 25, 2025 disclosing 50,167 shares of BridgeBio Pharma, Inc.. This represents a change in shares of -10.48% during the quarter. The current value of the position is $3,036,433 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-07-24 2025-05-31 NP BRIDGEBIO PHARMA EC US10806X1028 44,911 -5,256 -10.48 1,538 -12.11 0.0203
2025-04-25 2025-02-28 NP BRIDGEBIO PHARMA EC US10806X1028 50,167 1 0.00 1,751 28.87 0.0236
2025-01-27 2024-11-30 NP BRIDGEBIO PHARMA EC US10806X1028 50,166 350 0.70 1,359 -2.09 0.0184
2024-10-29 2024-08-31 NP BRIDGEBIO PHARMA EC US10806X1028 49,816 -1,210 -2.37 1,387 -2.94 0.0206
2024-07-26 2024-05-31 NP BRIDGEBIO PHARMA EC US10806X1028 51,026 -8,250 -13.92 1,429 -29.40 0.0226
2024-04-24 2024-02-29 NP BRIDGEBIO PHARMA EC US10806X1028 59,276 961 1.65 2,024 20.91 0.0338
2024-01-24 2023-11-30 NP BRIDGEBIO PHARMA EC US10806X1028 58,315 -6,883 -10.56 1,674 -14.15 0.0321
2023-10-27 2023-08-31 NP BRIDGEBIO PHARMA EC US10806X1028 65,198 1,050 1.64 1,950 121.59 0.0381
2023-07-26 2023-05-31 NP BRIDGEBIO PHARMA EC US10806X1028 64,148 210 0.33 880 20.55 0.0190
2023-04-27 2023-02-28 NP BRIDGEBIO PHARMA EC US10806X1028 63,938 1,575 2.53 730 25.00 0.0179
2023-01-26 2022-11-30 NP BRIDGEBIO PHARMA EC US10806X1028 62,363 1,645 2.71 584 -8.32 0.0146
2022-10-26 2022-08-31 NP BRIDGEBIO PHARMA EC US10806X1028 60,718 60,718 638 0.0159
2022-07-29 2022-05-31 NP BRIDGEBIO PHARMA EC US10806X1028 0 -32,049 -100.00 0 -100.00
2022-04-28 2022-02-28 NP BRIDGEBIO PHARMA EC US10806X1028 32,049 -10,212 -24.16 250 -85.45 0.0058
2022-01-25 2021-11-30 NP BRIDGEBIO PHARMA EC US10806X1028 42,261 1,118 2.72 1,712 -16.98 0.0358
2021-10-26 2021-08-31 NP BRIDGEBIO PHARMA EC US10806X1028 41,143 858 2.13 2,062 -13.55 0.0452
2021-07-22 2021-05-31 NP BRIDGEBIO PHARMA EC US10806X1028 40,285 144 0.36 2,385 -15.97 0.0593
2021-04-23 2021-02-28 NP BRIDGEBIO PHARMA EC US10806X1028 40,141 10,523 35.53 2,837 90.66 0.0739
2021-01-20 2020-11-30 NP BRIDGEBIO PHARMA EC US10806X1028 29,618 4,601 18.39 1,488 99.20 0.0445
2020-10-16 2020-08-31 NP BRIDGEBIO PHARMA EC US10806X1028 25,017 455 1.85 747 3.75 0.0231
2020-07-20 2020-05-31 NP BRIDGEBIO PHARMA EC US10806X1028 24,562 678 2.84 720 -5.39 0.0281
2020-04-24 2020-02-29 NP BRIDGEBIO PHARMA EC US10806X1028 23,884 23,884 761 0.0340
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.